Studies | Outcomes reported | Follow up time period |
---|---|---|
Hemert 2020 [13] | TLF, NACE, all-cause mortality, cardiac death, MI, stent thrombosis, late stent thrombosis, any unplanned revascularization, TLR, stroke, major bleeding | 12 months |
Romaguera 2022 [14] | TLF, cardiac death, MI, all-cause mortality, any revascularization, TVR, stent thrombosis, late stent thrombosis, acute and sub-acute stent thrombosis, definite, possible and probable stent thrombosis, major adverse cardiac events | 12 months |
Rozemeijer 2017 [15] | All-cause mortality, TLF, cardiac death, MI, TLR, TVR, any revascularization, stent thrombosis, definite, possible and probable stent thrombosis, early and late stent thrombosis, major adverse cardiac events, major bleeding (BARC ≥ 3) | 12 months |
Rozemeijer 2018 [16] | Major adverse cardiac events, TLF, all-cause death, cardiac death, MI, definite or probable stent thrombosis, stent thrombosis, stroke, TLR, major bleeding (BARC ≥ 3) | 12 months |